Antimalarial ocular toxicity in rheumatic disease

被引:2
|
作者
Bray, VJ [1 ]
Enzenauer, RJ
Enzenauer, RW
West, SG
机构
[1] Fitzsimons Army Med Ctr, Rheumatol Serv, Aurora, CO 80045 USA
[2] Fitzsimons Army Med Ctr, Ophthalmol Serv, Aurora, CO 80045 USA
关键词
D O I
10.1097/00124743-199806000-00017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:168 / 169
页数:2
相关论文
共 50 条
  • [21] OCULAR MANIFESTATIONS OF RHEUMATIC DISEASE - COOPERATION BETWEEN INTERNIST AND OPHTHALMOLOGIST
    TYNDALL, A
    STEIGER, U
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 1993, 202 (05) : 352 - 355
  • [22] SCREENING FOR ANTIMALARIAL TOXICITY
    EASTERBROOK, M
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 1993, 28 (02): : 51 - 52
  • [23] Avoiding Antimalarial Toxicity
    Rosenbaum, James T.
    Mount, George R.
    Youssef, Jameel
    Lin, Phoebe
    ARTHRITIS & RHEUMATOLOGY, 2016, 68 (08) : 1805 - 1809
  • [24] BETWEEN SCYLLA AND CHARYBDIS: THE TOXICITY OF GLUCOCORTICOIDS IN RHEUMATIC DISEASE
    Mackie, Sarah L.
    RHEUMATOLOGY, 2018, 57
  • [25] Risk Factors for Antimalarial-Induced Retinal Toxicity in Systemic Lupus Erythematosus and Other Rheumatic Diseases
    Cramarossa, Gemma
    Liu, Hsin-Yen
    Pope, Janet
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [26] NATURAL-HISTORY OF OCULAR INVOLVEMENT IN CHRONIC RHEUMATIC DISEASE IN CHILDREN
    CASELLATO, A
    COLOMBO, D
    MANCARELLA, G
    GERLONI, V
    FANTINI, F
    GATTINARA, M
    OPHTHALMOLOGY TODAY, 1988, 803 : 427 - 430
  • [27] OCULAR EFFECTS AND SAFETY OF ANTIMALARIAL AGENTS
    EASTERBROOK, M
    AMERICAN JOURNAL OF MEDICINE, 1988, 85 (4A): : 23 - 29
  • [28] OCULAR ELECTROPHYSIOLOGY AND SYNTHETIC ANTIMALARIAL AGENTS
    DARNAUD, B
    NUCCI, T
    LETRONE, S
    BINAGHI, M
    COSCAS, G
    ANNALES DE MEDECINE INTERNE, 1981, 132 (06): : 362 - 366
  • [29] DIAGNOSIS - OCULAR REACTION TO ANTIMALARIAL DRUGS
    LEWIS, GM
    ARCHIVES OF DERMATOLOGY, 1960, 82 (01) : 145 - 146
  • [30] Antimalarial drug toxicity - A review
    Taylor, WRJ
    White, NJ
    DRUG SAFETY, 2004, 27 (01) : 25 - 61